Skip to content

Preconditioning of the motor network with repetitive navigated transcranial magnetic stimulation (rnTMS) to improve neuro-oncological and functional outcome

Preconditioning of the motor network with repetitive navigated transcranial magnetic stimulation (rnTMS) to improve neuro-oncological and functional outcome - PRECON

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017232
Enrollment
148
Registered
2020-01-28
Start date
2023-11-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71

Interventions

Group 1: twice-daily rnTMS (1 Hz, 30 minutes, 1800 pulses/ session), duration of rnTMS depends on the individually available time until surgical resection (minimum 5 days, maximum 28 days) Group 2: tw

Sponsors

Klinik für Neurochirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Supratentorial glioma grade II – IV in a motor relevant area, (2) Infiltration of primary motor cortex or distance between tumor and corticospinal tract below 8mm (Rosenstock et al., 2017), (3) Study participation does not delay surgery, (4) Age > 18 years, (5) Able to give written informed consent

Exclusion criteria

Exclusion criteria: (1) Contraindications for receiving an MRI scan, (2) Contraindications for undergoing a TMS examination, (3) more than one seizure per week, (4) Surgery scheduled <5 days after potential inclusion, (5) Pregnancy, (6) Missing informed consent

Design outcomes

Primary

MeasureTime frame
- Motor status measured with the BMRC for upper extremities 3 months postoperatively - Gross total resection rate

Secondary

MeasureTime frame
(1) Motor status as measured by the BMRC (British Medical Research Council) score for upper extremities 7 days postoperatively, (2) Functional connectivity of the motor system in the resting-state fMRI after the rnTMS intervention, (3) Health-related quality of life (EORTC BN-20) 7 days and 3 months postoperatively, (4) Action Research Arm Test (ARAT) 7 days and 3 months postoperatively

Countries

Germany

Contacts

Public ContactMelina Engelhardt

Klinik für Neurochirurgie, Charité Universitätsmedizin Berlin

melina.engelhardt@charite.de004930450660597

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026